Activated PI3K-delta syndrome
Autosomal dominant
Immunodeficiency with lymphoproliferation caused by a single activating change in PIK3CD or PIK3R1.
What a diagnosis changes
A genetic diagnosis allows targeted treatment with leniolisib, a PI3K-delta inhibitor, alongside immunoglobulin replacement and lymphoma monitoring.
Also known as
APDS; senescent T-cells-lymphadenopathy-immunodeficiency syndrome due to p110delta-activating mutation
Includes 2 related subtypes ↓Hide subtypes ↑
- immunodeficiency 14
- immunodeficiency 36 with lymphoproliferation
